Wissenschaftliche Arbeiten

Prof. Dr. Erdem Çubukçu

47 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Ozkan Kanat, Erdem Cubukcu, Nilufer Avci, Ferah Budak, İlker Ercan, Mustafa Canhoroz, Fatih Olmez. Comparıson Of Three Dıfferent Treatment Modalıtıes In The Management Of Cancer Cachexıa. Tumori, 99:229-233.2013. (IF; 1,09)

    Quelle: Profilseite auf medicana.com.tr

  2. 2)Kanat O, Kilickap S, Korkmaz T, Ustaalioglu Oven BB, Canhoroz M, Cubukcu E, Tolunay S, Evrensel T, Manavoglu O. Primary small cell carcinoma of the breast: report of seven cases and review of the literature. Tumori. 2011 Jul-Aug;97(4):473-8. doi: 10.1700/950.10400. Review. PubMed PMID: 21989436. (IF; 1,014)

    Quelle: Profilseite auf medicana.com.tr

  3. 3)E. Cubukcu, O. F. Olmez, N. Avcı, M. Canhoroz, E. Kurt, O. Kanat, T. Evrensel, O. Manavoğlu. Identification of prognostic factors in patients with metastatic gastrointestinal stromal tumors. J BUON. 2012 Jul-Sep;17(3):517-21. PubMed PMID: 23033292.(IF<1)

    Quelle: Profilseite auf medicana.com.tr

  4. Omer Fatih Olmez, Erdem Cubukcu, Ahmet Sami Bayram, Unsal Akcali, Turkkan Evrensel, Cengiz Gebitekin. Clinical outcomes of lung metastasectomy in patients with colorectal cancer. World J Gastroenterol. 2012 Feb 21;18(7):662-5. doi: 10.3748/wjg.v18.i7.662. PubMed PMID: 22363137; .(IF; 2,37)

    Quelle: Profilseite auf medicana.com.tr

  5. 5)Bayrak M, Olmez OF, Kurt E, Cubukcu E, Evrensel T, Kanat O, Manavoglu O. Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer. Clin Transl Oncol. 2013 Apr;15(4):307-12. doi:10.1007/s12094-012-0921-0. Epub 2012 Aug 22. PubMed PMID: 22911549. .(IF;2,07)

    Quelle: Profilseite auf medicana.com.tr

  6. 6)Cubukcu E, Fatih Olmez O, Saraydaroglu O, Akcali U, Kanat O, Kurt E, Evrensel T, Manavoglu O. Immunohistochemical expression of excision repair cross-complementing 1 (ERCC1) in non-small-cell lung cancer: implications for patient outcome. Clin Transl Oncol. 2011 Nov;13(11):826-30. doi:10.1007/s12094-011-0741-7. PubMed PMID: 22082649.(IF;2,07)

    Quelle: Profilseite auf medicana.com.tr

  7. 7)Erdem Cubukcu, Ozkan Kanat, Omer Fatih Olmez, S. Kabul, M. Canhoroz, N. Avci, A. Deligönul, M. Hartavi, S. Cubukcu, F. Olmez, E. Kurt, T. Evrensel, S. Gokgoz, O. Manavoglu. Prognostic significance of estrogen receptor, progesterone receptor, HER/neu, Ki67, and nm23 expression in patients with invasive breast cancer. J BUON. 2013 Apr-June;18(2):359-365. .(IF<1)

    Quelle: Profilseite auf medicana.com.tr

  8. 8)Cubukcu E, Olmez OF, Kanat O, Kabul S, Canhoroz M, Avci N, Hartavi M, Deligonul A, Cubukçu S, Manavoglu O. Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer. Contemp Oncol (Pozn). 2014;18(1):34-8. (IF<1)

    Quelle: Profilseite auf medicana.com.tr

  9. 9)Kurt E, Cubukcu E, Karabulut B, Olmez OF, Kurt M, Avcı N, Ozdemir F, Tunali D, Evrensel T, Manavoglu. A multi-institutional evaluation of carboplatin plus docetaxel regimen in elderly patients with advanced gastric cancer. J BUON. vol.18,no.1,2013.(IF<1)

    Quelle: Profilseite auf medicana.com.tr

  10. 10)Saip P, Keskin S, Ozkan M, Kaplan MA, Aydogan F, Gonullu Demirag G, Uzunoglu S, Engin H, Basaran G, Guler N, Uygun K, Demirkan B, Ozdemir F, Cubukcu E, Salepci T, Cicin I. The access rate to diagnosis and treatment modalities in breast cancer patients in Turkey; multicenter observational study. J BUON. 2011 Oct-Dec;16(4):664-71. PubMed PMID: 22331719. .(IF<1)

    Quelle: Profilseite auf medicana.com.tr

  11. 11)Hartavi M, Kurt E, Oral B, Olmez OF, Cubukcu E, Deligonul A, Avci N, Manavoglu O. The SOCS-1 -1478CA/del polymorphism is not associated with colorectal cancer or age at onset in Turkish subjects. Asian Pac J Cancer Prev. 2013;14(12):7583-6.(IF;2,57)

    Quelle: Profilseite auf medicana.com.tr

  12. 12)M Karkucak, T Yakut, T Evrensel, A Deligonul, T Gulten, G Ocakoglu, E Kurt, O Kanat, E Cubukcu, İ Sehitoglu, M Canhoroz. XRCC1 Gene Polymorphisms and Risk of Lung Cancer in Turkish Patients. Int J Hum genet,12(2):113-117;2012(IF<1)

    Quelle: Profilseite auf medicana.com.tr

  13. 13)Olmez OF, Cubukcu E, Evrensel T, Kurt M, Avci N, Tolunay S, Bekar A, Deligonul A, Hartavi M, Alkis N, Manavoglu O. The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme. Clin Transl Oncol. 2013 Jun 6. [Epub ahead of print] PubMed PMID: 23740136.(IF;2,07)

    Quelle: Profilseite auf medicana.com.tr

  14. 14)Omer Fatıh Olmez, Turkkan Evrensel, Erdem Cubukcu, Nesrin Ugras, Nilufer Avcı, Mustafa Canhoroz, Adem Deligonul, Mustafa Hartavi, Fatma Olmez, Sinem Cubukcu, Sahsine Tolunay, Ender Kurt, Ozkan Kanat, Osman Manavoglu. Prognostic Significance of Human Epidermal Receptor (HER)-3 Immunohistochemical Expression in Patients with Metastatic Breast Cancer. Asian Pacific J Cancer Prev (ISI), .(IF;2,57)

    Quelle: Profilseite auf medicana.com.tr

  15. 15)Mustafa Canhoroz, Özkan Kanat, Özlem Saraydaroğlu, Emine Buluç, Nilüfer Avcı, Erdem Çubukçu, Ömer Fatih Ölmez, Osman Manavoğlu. Clinical significance of adiponectin expression in colon cancer patients. Journal of Cancer Research and Therapeutics. (IF<1)

    Quelle: Profilseite auf medicana.com.tr

  16. 16)Ulas A, Kos T, Avci N, Cubukcu E, Olmez OF, Bulut N, Degirmenci M.

    Quelle: Profilseite auf medicana.com.tr

  17. Patients with HER2-positive early breast cancer receiving adjuvant trastuzumab:

    Quelle: Profilseite auf medicana.com.tr

  18. clinicopathological features, efficacy, and factors affecting survival. Asian Pac J Cancer Prev. 2015;16(4):1643-9. . (IF;2,57)

    Quelle: Profilseite auf medicana.com.tr

  19. 17)Ulas A(1), Silay K, Akinci S, Dede DS, Akinci MB, Sendur MA, Cubukcu E, Coskun HS, Degirmenci M, Utkan G, Ozdemir N, Isikdogan A, Buyukcelik A, Inanc M, Bilici A, Odabasi H, Cihan S, Avci N, Yalcin B. Medication errors in chemotherapy preparation and administration: a survey conducted among oncology nurses in Turkey.Asian Pac J Cancer Prev. 2015;16(5):1699-705. (IF;2,57)

    Quelle: Profilseite auf medicana.com.tr

  20. 18)Avci N, Deligonul A, Tolunay S, Cubukcu E, Fatih Olmez O, Ulas A, Hartavi M,Kurt E, Evrensel T Neoadjuvant chemotherapy-induced changes inimmunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.J BUON. 2015 Jan-Feb;20(1):45-9. (IF<1)

    Quelle: Profilseite auf medicana.com.tr

  21. 19)Yerci O(1), Sehitoglu I, Ugras N, Cubukcu E, Yuce S, Bedir R, Cure E. Somatostatin receptor 2 and 5 expressions in gastroenteropancreatic neuroendocrine tumors in Turkey. Asian Pac J Cancer Prev. 2015;16(10):4377-81. (IF;2,57)

    Quelle: Profilseite auf medicana.com.tr

  22. 20)Ulas A, Avci N, Kos T, Cubukcu E, Olmez OF, Bulut N, Degirmenci M. Areneutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? J BUON. 2015 May Jun;20(3):714-22. PubMed PMID: 26214622. (IF<1)

    Quelle: Profilseite auf medicana.com.tr

  23. 21)Avci N, Deligonul A, Tolunay S, Cubukcu E, Fatih Olmez O, Altmisdortoglu O, Tanriverdi O, Aksoy A, Kurt E, Evrensel T. Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoingneoadjuvant chemotherapy. J BUON. 2015 JulAug;20(4):994-1000. PubMed PMID: 26416041. (IF<1)

    Quelle: Profilseite auf medicana.com.tr

  24. 22)Mehmet Ture, Tahsin Yakut, Adem Deligönül, Mutlu Karkucak, Sebnem Ozemri Sağ, Mustafa Hartavi, Erdem Cubukcu, Tuna Gülten, Turkkan Evrensel, Investigation Of Fgfr4(Gly388arg) Gene Polymorphism İn Primary Lung Cancer Patients, Int J Hum Genet 15(1);7-12 (2015)

    Quelle: Profilseite auf medicana.com.tr

  25. 23)Yalcin Cirak1,Yavuz Furuncuoglu2,Ozlem Yapicier3, Asude Aksu4,Erdem Cubukcu ,Aurora- A overexpression in breast cancer patients induces taxane resistance and results in worse prognosis accepted for publication in JBUON after peer review (vol.21,no.1,2016 issue).

    Quelle: Profilseite auf medicana.com.tr

  26. 24)Erdem Çubukçu, Mustafa Canhoroz, Ömer Fatih Ölmez, Özkan Kanat, Ender Kurt, Muharrem Erol, Sinem Çubukçu, Nadide Yorulmaz, Sami Bayram, Turkkan Evrensel, Osman Manavoglu. Cisplatin plus etoposide in the Adjuvant Treatment of Patients with Non-Small Cell Lung Cancer. Journal of Clinical and Analytical Medicine. Published Online: 02.01.2013DOI: 10.4328/JCAM.1469

    Quelle: Profilseite auf medicana.com.tr

  27. 25)Özkan Kanat, Erdem Çubukcu, Sinem Çubukcu, Mustafa Canhoroz, Savaş Aksoy, Oya Karadağ, Nihan Alkış, Osman Manavoğlu. Paclitaxel and Carboplatin in Elderly Patıents with Advanced Non-small Cell Lung Cancer. Journal of Clinical and Analytical Medicine 2012;3(3):293-295. DOI: 10.4328/JCAM.705

    Quelle: Profilseite auf medicana.com.tr

  28. 26)Sinem Çubukçu, Özkan Kanat, Erdem Çubukçu, Ömer Fatih Ölmez, Mustafa Canhoroz, Nilüfer Avci, Mustafa Hartavi, Adem Deligönül, Serdar Seyhan, Aylin Ayyıldız, Ünal Taşdemir, Osman Manavoğlu. Efficacy of Sunitinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors. Journal of Clinical and Analytical Medicine. Published Online: 04.12.2012. DOI: 10.4328/JCAM.1375

    Quelle: Profilseite auf medicana.com.tr

  29. 27)Nilüfer Avcı, Mehmet Ali Balcı, İrfan Esen, Gülen Tandoğan, Mustafa Merter, Erdem Çubukçu, Fatih Ölmez, Belkıs Nihan Coşkun, Mustafa Hartavi, Şahsine Tolunay. Bursa Bölgesinde Erkek Meme Kanserli Hastaların Genel Özellikleri. The Journal of Breast Health 2012;8(3):126-129.

    Quelle: Profilseite auf medicana.com.tr

  30. 28)P. Saip, S. Keskin, M. Özkan, M.A. Kaplan, F. Aydoğan, G. G. Demirağ, S. Uzunoğlu, H. Engin, G. Başaran, N. Güler, K. Uygun, B. Demirkan, F. Özdemir, E. Çubukçu, T. Salepçi, İ. Çiçin. Türkiyede Meme Kanserli Hastaların Tanı Ve Tedavi Yöntemlerine Ulaşım Hızı; Çok Merkezli Gözlemsel Çalışma. The Journal of Breast Health. 2012;7:109-117.

    Quelle: Profilseite auf medicana.com.tr

  31. 29)Erdem Cubukcu, Omer Fatih Olmez, Ozkan Kanat, Murat Pekgoz, Nesrin Ugras , Adem Deligonul, Osman Manavoglu. Malignant melanoma of the stomach in an elderly patient. The Turkish Journal of Gastroenterology.(kabul edildi)

    Quelle: Profilseite auf medicana.com.tr

  32. 30)Omer F Olmez, Erdem Cubukcu, Turkkan Evrensel, Ozkan Kanat, Ender Kurt, Elif U Akyıldız, Belkıs N Coskun, Osman Manavoglu. Pulmonary Actinomycosis Mimiching Metastasis From Lung Adenocarcinoma. Onkologie. 2012;35(10):604-6. doi: 10.1159/000342675. Epub 2012 Sep 18. PubMed PMID: 23038234.

    Quelle: Profilseite auf medicana.com.tr

  33. 31)Kanat O, Ozguc H, Yalcinkaya U, Cubukcu E. A case of granular cell tumor with an interesting clinical course. Indian J Dermatol Venereol Leprol. 2012 Mar Apr;78(2):193-5. doi: 10.4103/0378-6323.93643. PubMed PMID: 22421656.

    Quelle: Profilseite auf medicana.com.tr

  34. 32)Ozkan K, Sehsuvar G, Erdem C, Mustafa C, Ibrahim S, Fatih O. A rare occurrence of primary T-cell lymphoma of the breast in pregnancy. Acta Oncol. 2011 Nov;50(8):1262-3. doi: 10.3109/0284186X.2011.602116. Epub 2011 Aug 3. PubMed PMID: 21812625.

    Quelle: Profilseite auf medicana.com.tr

  35. 33)Olmez OFKinikoglu O Yilmaz NH Bilici A Çubukçu E., Seker M Cakir TYildiz O Hamdard J Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade J Oncol Pharm Pract. 1.908 1526-1530 25 2018

    Quelle: Profilseite auf medicana.com.tr

  36. 34)Caner B., Çubukçu E., Mide Kanserinde Adjuvan ve Perioperatif Tedavi Türkiye Klinikleri 55-60 5 2019

    Quelle: Profilseite auf medicana.com.tr

  37. 35)Çubukçu E.,çelik o Kanserde Palyatif Semptomatik Tedaviler: Kaşeksi, Halsizlik, İştahsızlık ve Tedavi Yaklaşımları Turkiye Klinikleri Journal of Medical Oncology Special Topics 2017

    Quelle: Profilseite auf medicana.com.tr

  38. 36)Çubukçu E., Deligönül A., Lokal İleri Prostat Kanserinde Multimodal Tedavisi: Tıbbi Onkoloji Perspektifi Turkiye Klinikleri Journal of Urology Special Topics 190-193 2017

    Quelle: Profilseite auf medicana.com.tr

  39. 37)Çubukçu E.,ocak bOlmez OFDeligonul Akacan t metastatik meme kanseri tedavisinde lapatinib kapesitabin kombinasyonunun retrospektıf değerlendirilmesi. uludag medical journal 2018

    Quelle: Profilseite auf medicana.com.tr

  40. 38)Çubukçu E.,ocak b Altmışbeş Yaş Üstü Metastatik Yumuşak Doku Sarkom Hastalarında Pazopanib Tedavisinin Etkinliğinin Retrospektif Değerlendirilmesi. 2019

    Quelle: Profilseite auf medicana.com.tr

  41. 39)Akaltun NZengi SMacun S Çubukçu E., Meme Kanserli Bir Hastada Vinorelbin Kemoterapisine Bağlı Ekstravazasyon Uludağ Üniversitesi Tıp Fakültesi Dergisi 79-84 2017

    Quelle: Profilseite auf medicana.com.tr

  42. 40)Erdem Çubukçu, Mustafa Canhoroz, Ömer Fatih Ölmez, Nilüfer Avcı, Sinem Çubukcu, Ünsal Akçalı, Mustafa Sakallı, Muharrem Bayrak, Özkan Kanat, Ender Kurt, Türkkan Evrensel, Osman Manavoğlu. Adjuvant Chemotherapy in Locally Advanced Bladder Cancer: Retrospective Analysis of 32 Cases. Uludag Medical Journal 2011, Cilt 37, Sayı 3, Sayfa(lar) 123-125

    Quelle: Profilseite auf medicana.com.tr

  43. 41)Erdem Çubukçu, Ender Kurt, Mutlu Karkucak, Ömer Fatih Ölmez, Adem Deligönül, Orhan Görükmez, Nermin Keni, Tahsin Yakut, Vildan Özkocaman, Osman Manavoğlu. A Case With Treatment Related AML-M4 Developing Endometrium Cancer. Uludag Medical Journal 2011, Cilt 37, Sayı 2, Sayfa(lar) 105-107

    Quelle: Profilseite auf medicana.com.tr

  44. 42)Muharrem Bayrak, Ömer Fatih Ölmez, Ender Kurt, Erdem Çubukçu, Nilüfer Avcı, Sinem Çubukçu, Pınar Söker, Osman Manavoğlu. The Relationship Between Pre-treatment Serum Levels of AFP, CEA and CA 19-9 and Clinicopathological Factors in Patients with Locally Advanced and Metastatic Gastric Cancer Uludag Medical Journal 2011, Cilt 37, Sayı 3, Sayfa(lar) 139-143

    Quelle: Profilseite auf medicana.com.tr

  45. 43)Ahmet Yağbasan, Canan Ersoy, Erdem Çubukçu, Ömer Fatih Ölmez, Şazi İmamoğlu. Morbid Obez Kadınlarda Sigara İçiminin Obezite İndeksleri, İnsülin Direnci, Kan Basıncı, Glisemi ve Lipid Parametreleri Üzerine Etkilerinin Retrospektif Olarak Değerlendirilmesi. Journal of Inonu University Medical Faculty, Vol 15, No 4 (2008)

    Quelle: Profilseite auf medicana.com.tr

  46. N. Avcı, M. Merter, M.A.Başcı, E. Cubukcu, Ö.F.Ölmez, G. Özkaya, M. Hafızoğlu, N. Yorulmaz, E. Hafızoğlu, Ö. Kanat. Lokal İleri veya Metastaik Pankreas Kanserli Hastalarımızın Retrospektif Değerlendirilmesi

    Quelle: Profilseite auf medicana.com.tr

  47. Çubukçu E., İmmunoterapilerde Yan Etki Yönetimi Türkiye Klinikleri 162-168 2019

    Quelle: Profilseite auf medicana.com.tr